Dr. Robert Thomas Chasse, MD

Dr. Chasse practices at TidalHealth Peninsula Regional in Salisbury, Maryland, part of TidalHealth Peninsula Regional.

Dr. Chasse's NPI, 1619967049, was assigned on October 26, 2005. Dr. Chasse graduated from Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School in 1986. Dr. Chasse holds Maryland license D0046080.

Dr. Chasse's primary practice is TidalHealth Peninsula Regional, at 100 East Carroll Avenue, Salisbury, MD 21801 in Wicomico County. The practice phone is (410) 546-6400.

Dr. Chasse's primary practice is TidalHealth Peninsula Regional in Salisbury, Maryland, part of TidalHealth Peninsula Regional. Dr. Chasse is also affiliated with TidalHealth Nanticoke. The medical group on file is TidalHealth Cardiovascular Surgery. Dmand AI also links Dr. Chasse to 1 more community health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chasse practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Chasse's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Chasse is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Chasse's licenses on file in 3 states: Maryland, Virginia and North Carolina.

Dmand AI lists acute respiratory failure, asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, chronic sinusitis, pulmonary fibrosis and sleep apnea among the conditions Dr. Chasse treats.

CMS data shows 823 Medicare services from Dr. Chasse across 14 procedure codes in 2024, for 413 Medicare patients. Medicare paid $75,738 for them.

CMS counts 413 Medicare patients who saw Dr. Chasse in 2024. The largest group is 75 to 84, with 164 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chasse's median patient age at 64, with 48% women.

In 2024, Dr. Chasse wrote 583 Medicare Part D claims for 99 patients. 46% of them were for generic drugs. CMS names the drug for 413 of them, across 16 drugs with 11 or more claims each, at $131,843 in total drug cost. In 2023, CMS named 431 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Chasse for performance year 2024, reported as part of a group. Dr. Chasse accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Chasse in 2015. The most frequent topics are Bronchoscopy. Dr. Chasse's most frequent co-authors are Sanjeev K. Ahuja, MD, Eric Scott Halstead, MD, PhD and Estelle S. Harris, MD.

Dmand AI links Dr. Chasse to 1 clinical trial. Conditions studied include COVID-19 and Pneumonia, Viral.

CMS Open Payments shows 788 general payments to Dr. Chasse from 60 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,356.

Dmand AI lists 1 award for Dr. Chasse, most recently CMS Stage 1 EHR in 2013.

Dr. Chasse graduated from Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School in 1986. Dr. Chasse is a member of ACP.

Dr. Chasse is in network with 14 carriers, including Blue Cross Blue Shield of Michigan, CareFirst BlueCross BlueShield and Cigna. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.